Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Introduction for the 5th International Meeting on Internet and Audiology Special Issue of the American Journal of Audiology.
Neuralgia, Postherpetic
Red cell distribution width: a measure of cardiovascular risk in rheumatoid arthritis patients?
MRI characterization of the dynamic effects of 5a-reductase inhibitors on prostate zonal volumes.
CRISPR-mediated Sox9 activation and RelA inhibition enhance cell therapy for osteoarthritis.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CRISPR-mediated Sox9 activation and RelA inhibition enhance cell therapy for osteoarthritis.
CRISPR-mediated Sox9 activation and RelA inhibition enhance cell therapy for osteoarthritis. Mol Ther. 2024 Aug 07; 32(8):2549-2562.
View in:
PubMed
subject areas
Animals
Cartilage, Articular
Cell- and Tissue-Based Therapy
Chondrocytes
Chondrogenesis
CRISPR-Cas Systems
Disease Models, Animal
Gene Editing
Humans
Mesenchymal Stem Cell Transplantation
Mice
Osteoarthritis
SOX9 Transcription Factor
Transcription Factor RelA
authors with profiles
Lan Zhao